News & Updates
Filter by Specialty:
TB vax primer augments BCG-induced immune response in bladder cancer patients
Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).
TB vax primer augments BCG-induced immune response in bladder cancer patients
15 Apr 2025
Shockwave therapy plus tadalafil beneficial to Asians with ED
In the treatment of mild to moderate erectile dysfunction (ED), low-intensity extracorporeal shockwave therapy combined with tadalafil helps improve outcomes, according to the preliminary results of a study from China.
Shockwave therapy plus tadalafil beneficial to Asians with ED
14 Apr 2025
Stepwise DAPT de-escalation on par with standard therapy in ACS
A stepwise dual antiplatelet therapy (DAPT) de-escalation strategy among patients with acute coronary syndrome (ACS) who could be treated by paclitaxel-coated balloons without stents demonstrates noninferiority to the standard 12-month DAPT for all net adverse clinical events, according to a study.
